Table 1

Summary statistics, final study sample

Characteristic*MDD (n = 506)Healthy controls (n = 358)p
Sex (male/female), no.198/308180/178< 0.001
Age, yr49.14 ± 7.28 (30.91–65.48)52.57 ± 7.94 (35.55–65.61)0.014
hsCRP, mg/dL0.28 ± 0.41 (0.02–3.80)0.17 ± 0.25 (0.02–2.20)< 0.001
Hamilton Depression Rating Scale, score13.74 ± 6.61 (0.00–33.00)NANA
Comorbidity index, score1.65 ± 0.81 (0.00–5.00)0.37 ± 0.61 (0.00–3.00)< 0.001
Center for Epidemiologic Studies Depression Scale, total score27.58 ± 12.16 (0.00–56.00)6.3 ± 4.09 (0.00–15.00)< 0.001
Inpatient episodes, no.1.61 ± 1.32 (0.00–10.00)NANA
Depressive episodes, no.6.22 ± 10.85 (1.00–99.00)NANA
Disease duration, mo80.71 ± 95.30 (2.00–506.00)NANA
Inventory of Depressive Symptomatology, sum score3.99 ± 2.86 (0.00–15.00)NANA
Body mass index, kg/m228.41 ± 5.39 (17.70–50.10)26.50 ± 3.93 (16.70–41.30)< 0.001
  • hsCRP = high-sensitivity C-reactive protein; MDD = major depressive disorder; NA = not applicable.

  • * Unless otherwise specified, results are presented as mean ± standard deviation (range); p-values derived from χ2, Mann–Whitney U and t-tests.

  • In the MDD group, for Hamilton Rating Scale for Depression, n = 504; for comorbidity index, n = 505; for Center for Epidemiologic Studies Depression Scale total, n = 500; for inpatient episodes, n = 498; for depressive episodes, n = 467; for disease duration, n = 501; for Inventory of Depressive Symptomatology sum score, n = 500.